ERLEADA®
(apalutamide)
Medical inquiries
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
ERLEADA® (apalutamide)
Medical Information
ERLEADA - SPARTAN Study
Last Updated: 02/18/2025
SUMMARY
A summary of this response is provided as an interactive PDF (iPDF) that can be accessed by clicking the following link:
- ERLEADA®
(apalutamide) - SPARTAN Study - Minimum requirement to access interactive content: Adobe Acrobat Reader
- The executive summary infographic of the iPDF content is provided below
